Lotus Pharmaceuticals

LTUS · OTC

$0.0049+$0.00 (+0.00%)TodayMarket open · Oct 20, 10:09 AM ET · Delayed 15 min

No price history for this range.

About LTUS

Lotus Pharmaceuticals, Inc. engages in the manufacture and distribution of pharmaceutical products in the People's Republic of China. The company is headquartered in Beijing, Beijing and currently employs 233 full-time employees. The company went IPO on 2012-05-15. The firm produces crude medicine and drugs in forms of tablets, capsules, granules, eye-drops, and freeze-dried powder injection. The firm's drug development is focused on the treatment of cerebro-cardiovascular disease, asthma, and diabetes. The firm operated in two business segment Wholesales segment and Retail segment. The firm's products include Maixin-valsartan capsules for the treatment of hypertension, Muxineye drops for the treatment of glaucoma and Yipubishan-octreotide Acetate Injection solution for the treatment of gastric ulcers. The firm mainly conducts its businesses in the domestic market and overseas markets.

Employees: 233
Headquarters: Beijing, Beijing
Listed: May 15, 2012
Sector: Health Care
Industry: Pharmaceuticals
Website: lotuspharmaceuticalsusa.com

Leadership

Lotus Pharmaceuticals executives
Name	Title	Since	Age
Zhongyi Liu	—	2006	50
Yan Zeng	—	—	52
Xing Shen	—	—	40
Lu Jun	—	—	31
Fan Lijun	—	—	42
Li Zhaohui	—	—	42

Similar companies

Companies in the same industry as Lotus Pharmaceuticals

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.